BRIEF-Immunovaccine announces positive phase 1 topline data for DepoVax-based respiratory syncytial virus vaccine candidate
Oct 13 (Reuters) - Immunovaccine Inc :
* Immunovaccine announces positive phase 1 topline data for depovax(tm)-based respiratory syncytial virus vaccine candidate
* Immunovaccine Inc - vaccine had a positive safety profile and was well tolerated with no serious adverse events among all study participants Source text for Eikon: Further company coverage:
© Thomson Reuters 2017 All rights reserved.